ResMed wins patent fight with Chinese firm

An administrative law judge at the International Trade Commission (ITC) rules that nine products manufactured by Chinese medical device maker BMC Medical Co., Ltd., infringe on one or more ResMed (RMD -0.6%) patents. Judge Thomas Pender recommends that the ITC ban BMC and its U.S. distributor, 3B Medical, from importing or selling any of the infringing products in the United States. He also recommends issuing a cease-and-desist order that would enjoin BMC and 3B from selling, advertising, marketing, storing or testing the infringing products in the U.S.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs